News

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Medscape1d
EMA Reverses Previous Refusal of Kisunla for Alzheimer's
Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...
Pharmaceutical Technology on MSN3d
Gilead wins positive European approval opinion for twice-yearly HIV injection
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...
DPA International on MSN6d
EMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
EU regulator green lights an injectable HIV drug that could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
EU regulator approves injectable HIV drug that experts say could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
Medscape2d
EMA Says No to Knee Cartilage Repair Therapy Jelrix
The European drug authority recommends refusal of marketing authorization due to evidence gaps in quality and efficacy.
EU regulator backs Eli Lilly's Alzheimer's drug after initial rejection
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
STAT6d
European regulators endorse Lilly’s Alzheimer’s treatment for certain patients
European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.